Chen Yang Luke Sells Shares of 111, Inc.

Chen Yang Luke sold 49,920 shares of 111, Inc. on June 12, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 3:00 PM EDT

Key Points

Chen Yang Luke sold 49,920 shares of 111, Inc. on June 12, 2026, with the transaction valued at $11,481.60.
111, Inc. trades on NasdaqGM under the ticker YI, with a market cap of $40.2 million and a forward P/E of 32.64.
Insiders also sold shares recently, including Sun Jian David, who sold multiple tranches in June 2026.

Chen Yang Luke recently sold 49,920 shares of 111, Inc. (NasdaqGM: YI) on June 12, 2026. The transaction was valued at $11,481.60, with the shares sold at an average price of $0.23 each. This was not part of a planned trading program.

Insider Buying and Selling at 111, Inc.

In addition to Chen Yang Luke's transaction, there were other notable insider sales at 111, Inc. Sun Jian David sold 58,800 shares on June 15, 2026, and had sold several other tranches earlier in the month, including 111,100 shares on June 11, 2026, at a similar average price.

Other Institutional Activity in 111, Inc.

Several institutional investors have also been active with 111, Inc. shares. Renaissance Technologies LLC increased its holdings by 300 shares, ending with 13,014 shares worth about $84,851. On the other hand, Serenus Wealth Advisors, LLC trimmed its position by 64 shares to hold 4,320 shares valued at approximately $321,334. Citigroup Inc added 207 shares, bringing its total to 207 shares valued at $1,341. Meanwhile, UBS Group AG significantly reduced its stake by 203 shares, leaving it with 100 shares worth $652.

111, Inc. Stock Snapshot

Shares of 111, Inc. are currently trading near $4.57 on the NasdaqGM. The company has a market capitalization of approximately $40.2 million and a forward P/E ratio of 32.64. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company's beta is 0.609, indicating lower volatility compared to the broader market.

Recent Earnings

111, Inc. reported revenue of about $11.39 billion, with a revenue growth rate of -33.1%, reflecting challenges in the past year. The company's net margin stands at -0.75%, and it has a return on equity of -14.84%. The next earnings report is expected on March 19, 2026.

About 111, Inc.

111, Inc., headquartered in Shanghai, China, operates an integrated online and offline healthcare platform. The company is involved in both B2C and B2B segments, offering supply chain services, online pharmacies, and healthcare product distribution. Founded in 2010, 111, Inc. serves a wide range of clients including pharmacies, pharmaceutical companies, and medical professionals.

Bottom Line

Insider activity at 111, Inc., including recent sales by Chen Yang Luke and Sun Jian David, provides a window into the company's current dynamics. As a healthcare player in China, 111, Inc. faces challenges reflected in its negative revenue growth and net margin. Investors track these insider transactions and institutional moves to gauge market sentiment, but it's important to remember that such filings are backward-looking and may not indicate future actions.